Piper Jaffray downgrades Biovail (NYSE: BVF) from Overweight to Neutral. PT lowered from $24 to $16.50.

Piper analyst says, "With ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE